GLP-1 Microdosing: The Conversation Mainstream Medicine Won't Have
Somewhere between "you don't qualify" and "here's your full dose," there's a whole conversation nobody is having. GLP-1 microdosing has quietly become one of the most requested and least understood protocols in metabolic medicine. Patients are asking for it. Clinics are offering it. The research to fully back it doesn't exist yet. We get honest about all three at once. We cover what microdosing actually means, why the approved doses are the approved doses, why so many women in perimenopause feel the standard protocol wasn't built for their body, and where the real risk lives — which is almost never where people think it is. Not a pitch. Not a warning label. The conversation you'd get with ninety minutes instead of eleven. Book a consultation: HERE · Follow: @culturecollectivebrands The new Wellness aesthetic Fusion Method: HERE Education only, not medical advice. GLP-1 receptor agonists are prescription medications with real contraindications. Talk to your own licensed provider.







